Start free trial
Healthcare

Renewals stopped falling through the cracks

Certificate expiry and sub-processor changes reopen the review on their own, so nothing waits for an annual calendar reminder.


Henrik Sund

Quality & Compliance, Aurea Bio

Published

2 min read

Results after a full renewal cycle

Of vendor renewals completed before the previous evidence expired
100%
Vendors operating on lapsed certification at any point in the year
0
Reviews reopened early by a monitoring signal rather than a calendar
19

Measured across 130 vendor renewals between May 2025 and May 2026.

An annual cycle that was only annual on paper

Aurea Bio reviewed every vendor once a year. The calendar said so, the policy said so, and the auditor was shown a spreadsheet that said so.

What actually happened is that a reminder fired twelve months after the last review, someone opened the vendor’s file, and discovered the SOC 2 report had expired four months earlier. The vendor had been operating outside the policy for a third of the year, and nothing in the process was capable of noticing. In the worst case found during the first migration, a sub-processor had changed eight months before anyone re-read the DPA.

The trigger is the evidence, not the date

Every artefact in the vault now carries its own expiry, and the review is scheduled against that rather than against the anniversary of the last one. A report due to lapse in March starts its renewal in January, whatever the calendar says.

Alongside it, three signals reopen a closed review on their own: a certification expiring or being withdrawn, a change to the vendor’s published sub-processor list, and a breach disclosure. None of those wait for a human to notice.

“The annual review was the thing we could prove we did. It was not the thing that kept us safe.”

A full cycle later

  • 130 renewals, all completed before the previous evidence expired. The old process averaged eleven that ran late each year, two of them by more than a quarter.
  • Nineteen reviews were reopened early by a signal rather than a date. Four of those were sub-processor changes that would not have surfaced until the next anniversary.
  • The auditor’s third-party sampling moved from “show me the review” to “show me the trigger”, which is a question the vault answers with a timestamp.

What’s next

Aurea Bio is pushing the same expiry model into supplier quality agreements, which live in a different system and still run on the calendar.


About Aurea Bio

Aurea Bio develops clinical diagnostics for hospital laboratories across Europe. 620 people in Copenhagen and Basel, ISO 13485 and ISO 27001 certified. Henrik Sund runs the quality and compliance function.

More customer stories

A locked shield rendered over a data centre, representing protected clinical records
Healthcare

−84% review time

38 days to 6, across 240 clinical vendors

A hospital group routed intake by data sensitivity instead of by whoever picked up the ticket. Two analysts clear the queue weekly.


Northwind Health

A compliance monitoring dashboard on a desk display in a darkened office
Fintech

0 audit findings

Walked into a PCI audit with the evidence already collected

Control responses, SOC 2 reports and pen tests were already in the vault when the assessor asked. Nobody spent the week chasing PDFs.


Ledgerline

Glowing data pathways routing across a dense circuit landscape
Marketplace

3× volume, same team

1,200 sellers onboarded without adding a reviewer

Low-risk sellers clear an automated tier in minutes; only the top two tiers reach a human. The review team stayed at four people.


Kestrel Market